Aradigm Corp. (ARDM) Misses Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. NVDA
5. OPCH
6. BBIO
7. GOOGL
8. AMD
9. CHRW
10. SKYD

Go back to Aradigm Corp. (ARDM) Misses Q4 EPS by 8c

Aradigm Announces Fourth Quarter 2015 and Full Year Financial Results

March 15, 2016 7:00 AM EDT

HAYWARD, Calif.--(BUSINESS WIRE)-- Aradigm Corporation (NASDAQ: ARDM) (the Company) today announced financial results for the fourth quarter and full year ended December 31, 2015.

Fourth Quarter 2015 Results

Since the Company has utilized the full amount of the $65 million of Grifols-funded budget provided under the inhaled ciprofloxacin collaboration arrangement which is recognized as revenue for reimbursement of its investigational drug Pulmaquin® inhaled ciprofloxacin project-related costs the Company recorded $35,000 in revenue in the fourth quarter of 2015 compared with $8.1 million in revenue in the fourth quarter of 2014. The Company will not be... More